Dear Colleague,
We are delighted that you have confirmed your consent and agreed to resubscribe to PCSK9 Forum to receive important information and updates from us.
Kind regards,
John Chapman and Henry Ginsberg
News
Alirocumab safe in patients with diabetes mellitusPROFICIO analysis shows consistent LDL lowering with evolocumabPROFICIO analysis shows consistent LDL lowering with evolocumabInternational Atherosclerosis Society and FH Foundation join forces to improve FH managementESC 2018: FOURIER analysis: Greater benefit with evolocumab in metabolic syndrome patientsESC 2018: FOURIER: Evolocumab shows similar benefit in men, women and the elderlyTwo more analyses show efficacy of alirocumab in diabetesOSLER: sustained benefit with evolocumab in statin intolerant patients
